Related Experiment Videos
Development of a sensitive multi-well colorimetric assay for active NFkappaB
P Renard1, I Ernest, A Houbion
1Laboratoire de Biologie et Biochimie Cellulaire, Facultés Universitaires Notre-Dame de la Paix, 61 rue de Bruxelles, B-5000 Namur, Belgium. patsy.renard@fundp.ac.be
Nucleic Acids Research
|February 13, 2001
Summary
Researchers developed a new, non-radioactive assay to rapidly screen for nuclear factor kappaB (NFkappaB) activation. This high-throughput method offers a sensitive and reproducible alternative to traditional radioactive gel shift assays for drug discovery.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Nuclear factor kappaB (NFkappaB) is a crucial transcription factor in immune responses, activated by inflammatory cytokines and microbial products.
- NFkappaB is a significant target for developing novel anti-inflammatory drugs.
- Current methods for assessing NFkappaB activation, like radioactive gel shift assays, are inconvenient and slow for high-throughput screening.
Purpose of the Study:
- To develop a novel, rapid, and convenient screening assay for NFkappaB activation.
- To provide a non-radioactive alternative to traditional methods for assessing NFkappaB DNA-binding capacity.
- To facilitate high-throughput screening for NFkappaB-targeted anti-inflammatory drug discovery.
Main Methods:
- A new DNA-binding assay was developed using multi-well plates coated with NFkappaB consensus oligonucleotide sequences.
- NFkappaB-bound DNA was detected using anti-NFkappaB antibodies.
- Detection was achieved through a colorimetric readout.
Main Results:
- The assay is easy to perform and non-radioactive.
- It demonstrates high reproducibility and specificity for NFkappaB.
- The assay is more sensitive than conventional radioactive gel shift assays.
- It is highly convenient for high-throughput screening applications.
Conclusions:
- The developed assay provides a practical and efficient method for assessing NFkappaB DNA-binding activity.
- This assay overcomes the limitations of traditional methods, enabling faster and more sensitive screening.
- It is a valuable tool for accelerating the discovery of new anti-inflammatory agents targeting NFkappaB.